Clinical Trials

Showing trials with last updates posted in 2021.

NCT00546793 | COMPLETED | PHASE1/PHASE2
32 participants

Ph I/II Study of Subcutaneously Administered Veltuzumab (hA20) in NHL and CLL

Study Type:
INTERVENTIONAL
Last Updated:
2021-08-16
Start Date:
2008-01-31
Completion:
2013-03-31
Conditions
  • NHL
  • Lymphoma, Non-Hodgkin
  • Lymphoma, B-Cell
  • Lymphoma, Follicular
  • Lymphoma, Intermediate-Grade
  • Lymphoma, Large-Cell
  • Lymphoma, Low-Grade
  • Lymphoma, Mixed-Cell
  • Lymphoma, Small-Cell
  • Leukemia, Lymphocytic, Chronic
  • Leukemia, B-Cell, Chronic
  • Leukemia, Prolymphocytic
  • Leukemia, Small Lymphocytic
  • Lymphoma, Small Lymphocytic
  • Lymphoma, Lymphoplasmacytoid, CLL
  • Lymphoplasmacytoid Lymphoma, CLL
  • CLL
  • SLL
Interventions
  • BIOLOGICAL
No Results Yet
NCT00421525 | COMPLETED | PHASE1/PHASE2
25 participants

Phase I/II Study of hLL1 in Multiple Myeloma

Study Type:
INTERVENTIONAL
Last Updated:
2021-08-16
Start Date:
2007-01-31
Completion:
2009-06-30
Conditions
  • Multiple Myeloma
  • Myeloma, Plasma-Cell
  • PLASMACYTOMA
Interventions
  • BIOLOGICAL
No Results Yet
NCT00421395 | COMPLETED | PHASE1/PHASE2
59 participants

Safety Study of NHL With 90Y-hLL2 IgG

Study Type:
INTERVENTIONAL
Last Updated:
2021-08-16
Start Date:
2002-08-31
Completion:
2007-10-31
Conditions
  • NHL
  • B-cell NHL
  • Non-Hodgkins Lymphoma
Interventions
  • BIOLOGICAL
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page